Summary of your 'study carrel' ============================== This is a summary of your Distant Reader 'study carrel'. The Distant Reader harvested & cached your content into a collection/corpus. It then applied sets of natural language processing and text mining against the collection. The results of this process was reduced to a database file -- a 'study carrel'. The study carrel can then be queried, thus bringing light specific characteristics for your collection. These characteristics can help you summarize the collection as well as enumerate things you might want to investigate more closely. This report is a terse narrative report, and when processing is complete you will be linked to a more complete narrative report. Eric Lease Morgan Number of items in the collection; 'How big is my corpus?' ---------------------------------------------------------- 48 Average length of all items measured in words; "More or less, how big is each item?" ------------------------------------------------------------------------------------ 2428 Average readability score of all items (0 = difficult; 100 = easy) ------------------------------------------------------------------ 49 Top 50 statistically significant keywords; "What is my collection about?" ------------------------------------------------------------------------- 17 SARS 8 MERS 7 COVID-19 4 patient 3 virus 3 uenza 3 infl 3 health 3 disease 3 Hong 3 East 2 viral 2 risk 2 infection 2 care 2 PCR 2 Middle 2 H5N1 2 CoV 2 China 2 COVID19 1 vaccine 1 treatment 1 test 1 symptom 1 sponge 1 serological 1 rotavirus 1 respiratory 1 receptor 1 product 1 polymorphism 1 pilgrim 1 passport 1 passenger 1 nitazoxanide 1 nasal 1 marine 1 malaria 1 load 1 like 1 influenza 1 immunity 1 ice 1 gene 1 gastroenteritis 1 ethnic 1 enterovirus 1 droplet 1 coronavirus Top 50 lemmatized nouns; "What is discussed?" --------------------------------------------- 1058 infection 1036 patient 909 virus 660 disease 596 % 589 study 588 case 532 health 511 coronavirus 457 symptom 448 response 422 vaccine 404 treatment 393 day 381 antibody 364 risk 346 cell 333 care 326 transmission 316 syndrome 312 outbreak 285 influenza 276 group 267 sample 266 contact 264 worker 253 datum 234 infl 225 time 216 control 209 use 208 testing 206 analysis 205 individual 200 test 200 protein 198 child 197 adult 195 people 186 camel 180 immunity 177 hospital 172 drug 171 year 167 population 167 pandemic 163 load 161 agent 160 number 155 country Top 50 proper nouns; "What are the names of persons or places?" -------------------------------------------------------------- 815 SARS 461 MERS 366 CoV-2 339 CoV 283 COVID-19 253 uenza 166 China 156 PCR 146 H5N1 127 A 111 Middle 111 Hong 111 East 109 H7N9 102 Hajj 100 RNA 98 Kong 96 eff 96 RT 96 Health 89 infl 84 fi 78 Africa 76 diff 72 H1N1 67 nitazoxanide 67 Lancet 65 CI 62 mg 59 • 59 USA 59 Singapore 53 Feb 52 Saudi 51 sera 51 US 51 C 49 Ebola 49 Arabia 46 haemagglutinin 46 Wuhan 46 T 46 IgG 44 Jan 43 IgM 43 B 42 gure 42 fl 42 CT 38 ective Top 50 personal pronouns nouns; "To whom are things referred?" ------------------------------------------------------------- 515 we 185 it 122 they 30 them 29 i 17 he 9 themselves 8 us 7 itself 5 you 3 him 2 she 2 one 1 mg 1 herself 1 duck/ Top 50 lemmatized verbs; "What do things do?" --------------------------------------------- 5256 be 1415 have 358 do 333 use 308 associate 270 include 268 show 234 report 234 infect 199 cause 171 identify 161 suggest 160 increase 159 provide 158 need 149 base 143 detect 142 develop 136 test 134 reduce 132 require 127 isolate 117 find 113 relate 112 assess 111 occur 111 emerge 106 compare 97 confirm 92 take 91 induce 88 give 87 remain 85 neutralise 85 control 84 contain 83 lead 81 make 77 follow 75 treat 75 improve 75 estimate 75 describe 74 result 74 obtain 71 receive 71 expose 71 consider 65 become 64 involve Top 50 lemmatized adjectives and adverbs; "How are things described?" --------------------------------------------------------------------- 589 not 562 respiratory 436 human 415 viral 375 clinical 362 severe 311 - 310 acute 304 high 282 other 259 also 258 such 256 more 221 infectious 215 public 196 avian 192 low 185 new 178 only 178 most 167 however 163 positive 152 early 140 novel 132 rotavirus 131 available 130 immune 129 common 128 global 124 important 121 rapid 121 many 114 large 111 several 111 negative 110 potential 110 non 106 serological 106 first 101 antiviral 98 like 97 asymptomatic 96 specific 95 further 94 well 92 similar 92 anti 91 possible 88 mild 88 likely Top 50 lemmatized superlative adjectives; "How are things described to the extreme?" ------------------------------------------------------------------------- 66 most 24 least 22 large 20 high 20 good 17 Most 15 great 5 late 4 low 4 early 4 close 4 bad 3 big 2 near 2 long 1 small 1 safe 1 fast 1 broad Top 50 lemmatized superlative adverbs; "How do things do to the extreme?" ------------------------------------------------------------------------ 112 most 31 least 4 well 1 hard Top 50 Internet domains; "What Webbed places are alluded to in this corpus?" ---------------------------------------------------------------------------- 1 doi.org 1 clinicaltrials Top 50 URLs; "What is hyperlinked from this corpus?" ---------------------------------------------------- 1 http://doi.org/10.1016/S1473-3099(20)30634-4 1 http://clinicaltrials Top 50 email addresses; "Who are you gonna call?" ------------------------------------------------- 1 tmadani@kau.edu.sa 1 cbauch@uwaterloo.ca Top 50 positive assertions; "What sentences are in the shape of noun-verb-noun?" ------------------------------------------------------------------------------- 4 viruses do not 3 patients did not 3 vaccine was poorly 2 % had aspergillus 2 % were asymptomatic 2 cases did not 2 day is greater 2 diseases are likely 2 diseases is important 2 patients are still 2 patients had enterovirus 2 patients had mild 2 patients had rotavirus 2 patients is similar 2 patients were positive 2 patients were seropositive 2 patients were younger 2 responses did not 2 sars is unknown 2 sars was effectively 2 sars was eventually 2 study has several 2 treatment reduced mortality 2 vaccine has not 2 vaccine was more 2 vaccines were clinically 2 virus infecting human 2 virus was not 1 % did not 1 % had allergic 1 % had diarrhoea 1 % had enterovirus 1 % had fatigue 1 % were critically 1 % were penicillin 1 % were resistant 1 antibodies provide protection 1 antibodies were less 1 antibodies were ready 1 antibodies were susceptible 1 antibody based assays 1 antibody is not 1 antibody test results 1 antibody testing only 1 care are especially 1 care have fungal 1 case reports biosecurity 1 case was symptomatic 1 cases are common 1 cases are infectious Top 50 negative assertions; "What sentences are in the shape of noun-verb-no|not-noun?" --------------------------------------------------------------------------------------- 5 study had no role 2 virus was not present 1 antibody is not detectable 1 cells was not signifi 1 cov did not generally 1 covid-19 is not certain 1 diseases did not widely 1 groups was not signifi 1 health has not yet 1 health is not feasible 1 patients are not only 1 patients had no disease 1 patients is not necessary 1 response is not necessarily 1 study had no funding 1 study was not aff 1 transmission is not uncommon 1 viruses do not typically A rudimentary bibliography -------------------------- id = cord-321949-s1qu3odd author = Anderson, Evan J title = Rotavirus infection in adults date = 2004-01-28 keywords = adult; child; gastroenteritis; infection; rotavirus summary = doi = 10.1016/s1473-3099(04)00928-4 id = cord-292749-f15h3315 author = Azman, Andrew S title = From China: hope and lessons for COVID-19 control date = 2020-04-03 keywords = China summary = doi = 10.1016/s1473-3099(20)30264-4 id = cord-288867-iicfe7il author = Bauch, Chris T title = COVID-19: when should quarantine be enforced? date = 2020-05-20 keywords = COVID-19 summary = These questions are how we might think of some of the dilemmas created by the COVID-19 pandemic, which presents us with difficult trade-offs in equity, economics, public health, and civil liberties. Plainly put, they ask the question: should health authorities place potentially exposed individuals into a quarantine setting where their separation from others can be enforced, or should authorities simply let them go home, ask them to avoid contacts, and monitor them for COVID-19 symptoms through phone calls or health-care visits? Aware of this dilemma, Peak and colleagues 1 use a mathematical model of the early spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to establish the conditions under which individual quarantine works better than active monitoring. Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study doi = 10.1016/s1473-3099(20)30428-x id = cord-315130-8g2ih8zl author = Bax, Adriaan title = SARS-CoV-2 transmission via speech-generated respiratory droplets date = 2020-09-11 keywords = droplet; viral summary = doi = 10.1016/s1473-3099(20)30726-x id = cord-268074-9mact9br author = Bi, Qifang title = Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study date = 2020-04-27 keywords = SARS; Shenzhen summary = doi = 10.1016/s1473-3099(20)30287-5 id = cord-317795-689at1qx author = Bielicki, Julia A title = Monitoring approaches for health-care workers during the COVID-19 pandemic date = 2020-07-23 keywords = COVID-19; SARS; care; health summary = doi = 10.1016/s1473-3099(20)30458-8 id = cord-273910-fna7s9te author = Bochud, Pierre-Yves title = Innate immunogenetics: a tool for exploring new frontiers of host defence date = 2007-07-20 keywords = RNA; Toll; gene; like; polymorphism; receptor summary = doi = 10.1016/s1473-3099(07)70185-8 id = cord-272135-a09bf50o author = Brouqui, Philippe title = Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease date = 2009-04-22 keywords = HID; HLIU; SARS; care; patient summary = doi = 10.1016/s1473-3099(09)70070-2 id = cord-354881-7o20cn1x author = Brown, Rebecca C H title = The scientific and ethical feasibility of immunity passports date = 2020-10-16 keywords = SARS; immunity; passport summary = doi = 10.1016/s1473-3099(20)30766-0 id = cord-282530-55lhjfm8 author = Carsana, Luca title = Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study date = 2020-06-08 keywords = COVID-19; SARS; case summary = doi = 10.1016/s1473-3099(20)30434-5 id = cord-277342-40d24mvm author = Chen, Yu title = SARS-CoV-2: virus dynamics and host response date = 2020-03-23 keywords = SARS summary = In The Lancet Infectious Diseases, Kelvin To and colleagues 4 report the viral load and antibody profiles of a cohort of 23 patients admitted to hospital with COVID-19. First, the high viral load during the early phase of illness suggests that patients could be most infectious during this period, and it might account for the high transmissibility of SARS-CoV-2. Second, age was associated with viral load in this study, which could explain the high degree of severe disease in older patients with SARS-CoV-2. 5, 6 The high viral load in elderly patients is associated not only with low immunity but also with high expression of the ACE2 receptor (the cellentry receptor for SARS-CoV-2) in older adults. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore doi = 10.1016/s1473-3099(20)30235-8 id = cord-288807-sw6teq1n author = Cook, Marion title = Potential factors linked to high COVID-19 death rates in British minority ethnic groups date = 2020-07-17 keywords = ethnic summary = key: cord-288807-sw6teq1n title: Potential factors linked to high COVID-19 death rates in British minority ethnic groups cord_uid: sw6teq1n 2·3 12·5 0 indicates absent or very low prevalence. NA=not available, although sickle cell trait was found in babies of all ethnic groups in the NHS sickle cell and thalassaemia data report, 2013-14. 5 *Predicted COVID-19 fatalities based on geography and demographics and actual hospital deaths, relative to white British, by ethnic group. Table: COVID-19 fatalities and prevalence of haemolytic disorders and anaemia among UK ethnic groups Mapping the presence of sickle cell and beta-thalassaemia in England: estimating and validating ethnic-specific rates European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis The epidemiology of the haemoglobin level-a study of 1057 subjects in general practice NHS Sickle Cell and Thalassaemia Screening Programme. Data report 2013/14. Are some ethnic groups more vulnerable to COVID-19 than others? London: The Institute for Fiscal Studies doi = 10.1016/s1473-3099(20)30583-1 id = cord-270602-599vweqe author = Donia, Marwa title = Marine natural products and their potential applications as anti-infective agents date = 2003-05-22 keywords = MIC; activity; marine; product; sponge summary = Although many marine-product clinical trials are for cancer chemotherapy, drug resistance, emerging infectious diseases, and the threat of bioterrorism have all contributed to the interest in assessing natural ocean products in the treatment of infectious organisms. Many marine natural products have successfully advanced to the late stages of clinical trials, including dolastatin 10, ecteinascidin-743, kahalalide F, and aplidine, and a growing number of candidates have been selected as promising leads for extended preclinical assessment. Many marine natural products have successfully advanced to the late stages of clinical trials, including dolastatin 10, ecteinascidin-743, kahalalide F, and aplidine, and a growing number of candidates have been selected as promising leads for extended preclinical assessment. 6 In this review, we focus on the pharmacologically tested marine leads that have shown in-vivo efficacy or potent invitro activity against infectious and parasitic diseases, including malaria, toxoplasmosis, trypanosomiasis, and viral, bacterial, and fungal infections. doi = 10.1016/s1473-3099(03)00655-8 id = cord-293540-45awgabp author = Drancourt, Michel title = Point-of-care testing for community-acquired pneumonia date = 2013-07-23 keywords = POC; virus summary = The rate and timing of pandemic A H1N1 virus infections might have revealed the diff erences in H7N9 disease outcome, by contrast with historical infections with seasonal infl uenza A H3N2 viruses. To avoid this delay, we introduced point-of-care (POC) microbiology laboratories near emergency departments where patients with community-acquired pneumonia are seen fi rst. However, it should be noted that not all pathogens that can cause community-acquired pneumonia can be detected by POC tests, and molecular tests for Staphylococus aureus have not been approved by the US Food and Drug Administration (FDA) or the European Conformity (CE). 9 This new capacity of POC tests increases the number of diagnoses 11 and underscores that community-acquired pneumonia can result from co-infection with several pathogens, 10 which will challenge common notions about causation and management. Furthermore, detection by POC testing of an abnormal increase in group A streptococci might suggest co-infection with infl uenza. doi = 10.1016/s1473-3099(13)70165-8 id = cord-279557-hk77e3pp author = Drosten, Christian title = Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection date = 2013-06-17 keywords = Germany; MERS; patient; virus summary = doi = 10.1016/s1473-3099(13)70154-3 id = cord-011468-1ienwzy8 author = Durrheim, David N title = When does a major outbreak become a Public Health Emergency of International Concern? date = 2020-05-19 keywords = PHEIC summary = The International Health Regulations 3 do not require actual international spread, only a high potential for that spread, and thus the criteria for a PHEIC had already been met by the second Emergency Committee meeting. Global health scholars have criticised the Emergency Committee process as lacking transparency, using "irrelevant considerations, undue influence and political interference", 5 and delaying declaration when International Health Regulations criteria have been met. 7 By the time the Emergency Committee declared a PHEIC for COVID-19 on Jan 30, 2020, 7736 cases and 179 deaths had been confirmed in mainland China, with 107 cases confirmed in 21 other countries. Level 1 PHEIC alert should indicate a high risk outbreak in a single country, with the potential for international spread requiring concerted public health efforts to contain and manage it locally. statement-on-the-meeting-of-theinternational-health-regulations-(2005)-emergency-committee-forebola-virus-disease-in-the-democratic-republic-of-the-congo doi = 10.1016/s1473-3099(20)30401-1 id = cord-261133-m00gcci4 author = Eccles, Ron title = Understanding the symptoms of the common cold and influenza date = 2005-10-25 keywords = URTI; common; nasal; symptom summary = 52 The mechanism of headache caused by cytokines is unknown but it is interesting that headache induced by cytokines is accompanied by symptoms such as fatigue, anorexia, malaise, nausea, and depression, and these symptoms are commonly associated with URTIs. A sensation of chilliness is an early symptom of common cold, 7 and is sometimes explained as an initial stage of fever, since vasoconstriction of skin blood vessels may cause a fall in skin temperature that is perceived as chilliness. 65 The cytokine stimulation of prostaglandin E2 production in skeletal muscle, and the effects of prostaglandin E2 on sensory nerves in muscle, may explain the myalgia associated with URTIs. In a study of common cold symptoms induced by challenge with infected nasal secretions, URTI symptoms were classified as either "early" or "later" symptoms. doi = 10.1016/s1473-3099(05)70270-x id = cord-275521-dlp055z8 author = Goldman, Emanuel title = Exaggerated risk of transmission of COVID-19 by fomites date = 2020-07-03 keywords = SARS summary = doi = 10.1016/s1473-3099(20)30561-2 id = cord-318683-1yxurnev author = Green, Manfred S title = Confronting the threat of bioterrorism: realities, challenges, and defensive strategies date = 2018-10-16 keywords = Ebola; agent; anthrax; disease; risk; vaccine summary = doi = 10.1016/s1473-3099(18)30298-6 id = cord-267436-mivxm8oh author = Groneberg, David A title = Treatment and vaccines for severe acute respiratory syndrome date = 2005-03-10 keywords = SARS; acute; coronavirus; respiratory summary = The causative agent of severe acute respiratory syndrome (SARS), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002-2003 outbreak, is a coronavirus that was unknown before the outbreak. The causative agent of severe acute respiratory syndrome (SARS), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002-2003 outbreak, is a coronavirus that was unknown before the outbreak. 31 The results of a randomised clinical study in Guangdong, involving multiple different treatment arms, suggest that ribavirin given at a low dose (400-600 mg/day) was less effective compared with an early and aggressive use of steroids with interferon alfa. Search terms were "severe acute respiratory syndrome", "SARS", "treatment", "coronavirus", "infection", "SARS coronavirus", "vaccination", and "antiviral". Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus doi = 10.1016/s1473-3099(05)01307-1 id = cord-316201-08pyx98r author = Grout, Andrea title = Guidelines, law, and governance: disconnects in the global control of airline-associated infectious diseases date = 2017-02-01 keywords = air; disease; passenger summary = doi = 10.1016/s1473-3099(16)30476-5 id = cord-281529-2rec51xg author = Haagmans, Bart L title = Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation date = 2013-12-17 keywords = CoV; East; MERS; PCR summary = doi = 10.1016/s1473-3099(13)70690-x id = cord-269838-1943g1ha author = Haffizulla, Jason title = Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial date = 2014-05-19 keywords = infl; nitazoxanide; uenza summary = doi = 10.1016/s1473-3099(14)70717-0 id = cord-329200-o5hxpl8f author = Houlihan, Catherine F title = The complexities of SARS-CoV-2 serology date = 2020-09-23 keywords = SARS summary = doi = 10.1016/s1473-3099(20)30699-x id = cord-314734-ai0hz4uq author = Hung, Ivan Fan-Ngai title = SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series date = 2020-06-12 keywords = Hong; Kong; SARS summary = doi = 10.1016/s1473-3099(20)30364-9 id = cord-279765-sb1ifyfx author = Isakova-Sivak, Irina title = A promising inactivated whole-virion SARS-CoV-2 vaccine date = 2020-10-15 keywords = SARS summary = In this regard, the study by Shengli Xia and colleagues 7 is timely because it provides valuable evidence for the safety and immunogenicity of a β-propiolactone inactivated aluminium hydroxideadjuvanted whole-virion SARS-CoV-2 vaccine candidate developed by China National Biotec Group and the Beijing Institute of Biological Products (BBIBP-CorV), which was tested in randomised, double-blind, placebocontrolled phase 1/2 clinical trials in healthy individuals aged 18 years and older. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial doi = 10.1016/s1473-3099(20)30832-x id = cord-337491-ztco6guw author = Kucharski, Adam J title = Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings date = 2020-08-03 keywords = SARS summary = doi = 10.1016/s1473-3099(20)30579-x id = cord-289744-suiqh3gv author = Lafolie, Jérémy title = Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis-like disease, or suspected meningitis: a prospective, multicentre, observational cohort study date = 2018-10-30 keywords = CSF; PCR; enterovirus summary = doi = 10.1016/s1473-3099(18)30479-1 id = cord-305193-hbn69kmi author = Lang, Min title = Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT date = 2020-04-30 keywords = COVID19 summary = doi = 10.1016/s1473-3099(20)30367-4 id = cord-009476-4emc4o6n author = Madani, Tariq A title = Case definition and management of patients with MERS coronavirus in Saudi Arabia date = 2014-09-22 keywords = CoV; MERS summary = 16 outbreak and prevent human-to-human and animalto-human transmission; an appropriate management algorithm, including best-practice guidelines for accurate diagnosis, infection control, intensive care, emergency medicine, and treatment; prioritise research related to the MERS-CoV outbreak such as case-control and cohort studies, seroprevalence studies, and clinical trials; and to eff ectively monitor outbreak control activities. 2 The new case defi nition (appendix) was developed based on reported health-care-associated MERS-CoV pneumonia (added as category 2 in the new case defi nition) and non-respiratory characteristics of patients with confi rmed infection who fi rst presented with acute febrile dengue-like illness with body aches, leucopenia, and thrombocytopenia (added as category 3). WHO Revised interim case defi nition for reporting to WHO-Middle East respiratory syndrome coronavirus (MERS-CoV): as of First confi rmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and Public Health Authorities doi = 10.1016/s1473-3099(14)70918-1 id = cord-291821-ovfqfurf author = Memish, Ziad A title = Emergence of medicine for mass gatherings: lessons from the Hajj date = 2011-12-19 keywords = Arabia; Hajj; Mecca; Saudi; health; pilgrim summary = doi = 10.1016/s1473-3099(11)70337-1 id = cord-332238-qw2ual51 author = Meyer, Jaimie P title = COVID-19 and the coming epidemic in US immigration detention centres date = 2020-04-15 keywords = ice summary = Individuals in US Immigration and Customs Enforcement (ICE) detention are at risk from serious consequences resulting from the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and inadequate access to appropriate medical care. In the USA, a rapid increase in SARS-CoV-2 infections in every state of the country has resulted in a growing number of hospitalisations, admissions to intensive care units, and deaths in specific age groups and in many people with underlying medical conditions. 1 Individuals who are incarcerated, including immigrants in ICE detention, are among the most vulnerable to infection and complicated disease because of existing drivers of inequality. Immigrants in ICE detention around the country have expressed panic over conditions that put them at exceptionally high risk of an outbreak of COVID-19 and proposed an immediate humanitarian response to mitigate the risk of infection. These actions should include the immediate release on humanitarian parole of individuals at risk of severe disease and death due to COVID-19 infection. doi = 10.1016/s1473-3099(20)30295-4 id = cord-261533-73721b24 author = Mok, Chris Ka Pun title = T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study date = 2020-10-06 keywords = Africa; MERS summary = doi = 10.1016/s1473-3099(20)30599-5 id = cord-332237-8oykgp0h author = Omrani, Ali S title = Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study date = 2014-09-29 keywords = East; MERS; Middle summary = doi = 10.1016/s1473-3099(14)70920-x id = cord-320970-ru2iw0py author = Peeling, Rosanna W title = Serology testing in the COVID-19 pandemic response date = 2020-07-17 keywords = COVID-19; SARS; test summary = doi = 10.1016/s1473-3099(20)30517-x id = cord-265769-96p07nyz author = Perlman, Stanley title = MERS-CoV in Africa—an enigma with relevance to COVID-19 date = 2020-10-06 keywords = MERS summary = doi = 10.1016/s1473-3099(20)30578-8 id = cord-278256-dmrtsxik author = Qiu, Haiyan title = Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study date = 2020-03-25 keywords = COVID-19; SARS; patient summary = doi = 10.1016/s1473-3099(20)30198-5 id = cord-303272-1w8epdht author = Reusken, Chantal BEM title = Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study date = 2013-08-09 keywords = East; MERS; Middle; OC43 summary = doi = 10.1016/s1473-3099(13)70164-6 id = cord-331244-zaguyxm5 author = Stephenson, Iain title = Confronting the avian influenza threat: vaccine development for a potential pandemic date = 2004-07-30 keywords = H5N1; H9N2; Hong; influenza; virus summary = doi = 10.1016/s1473-3099(04)01105-3 id = cord-313615-cts45n3j author = Tam, John S title = Research agenda for mass gatherings: a call to action date = 2012-01-15 keywords = disease; health; risk summary = doi = 10.1016/s1473-3099(11)70353-x id = cord-272274-p3oulo34 author = Teboh-Ewungkem, Miranda I title = COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality date = 2020-09-21 keywords = malaria summary = doi = 10.1016/s1473-3099(20)30763-5 id = cord-296573-4c9gch5b author = To, Kelvin KW title = The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities date = 2013-08-19 keywords = H5N1; H7N9; Hong; infl; uenza summary = doi = 10.1016/s1473-3099(13)70167-1 id = cord-254478-scc9wee0 author = To, Kelvin Kai-Wang title = Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study date = 2020-03-23 keywords = SARS; load; patient; viral summary = doi = 10.1016/s1473-3099(20)30196-1 id = cord-279001-l5ogbl5p author = Wilder-Smith, Annelies title = Can we contain the COVID-19 outbreak with the same measures as for SARS? date = 2020-03-05 keywords = COVID19; China; SARS summary = COVID-19 differs from SARS in terms of infectious period, transmissibility, clinical severity, and extent of community spread. Even if traditional public health measures are not able to fully contain the outbreak of COVID-19, they will still be effective in reducing peak incidence and global deaths. In November, 2002, the severe acute respiratory syn drome coronavirus (SARSCoV) emerged in China causing global anxiety as the outbreak rapidly spread, and by July, 2003, had resulted in over 8000 cases in 26 countries. In the absence of vaccines and specific treatment, the only available public health tools to control persontoperson transmittable diseases are isolation and quarantine, social distancing, and community containment measures. Isolation, quarantine, social distancing and community containment: pivotal role for oldstyle public health measures in the novel coronavirus (2019nCoV) outbreak Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto doi = 10.1016/s1473-3099(20)30129-8 id = cord-269264-ebqq8x8a author = Winter, Amy K title = The important role of serology for COVID-19 control date = 2020-04-21 keywords = serological summary = doi = 10.1016/s1473-3099(20)30322-4 id = cord-322290-zx3i8mpo author = Yelin, Dana title = Long-term consequences of COVID-19: research needs date = 2020-09-01 keywords = COVID-19 summary = doi = 10.1016/s1473-3099(20)30701-5 id = cord-267476-j59tm40d author = Yong, Sarah Ee Fang title = Connecting clusters of COVID-19: an epidemiological and serological investigation date = 2020-04-21 keywords = COVID-19; Church; SARS summary = doi = 10.1016/s1473-3099(20)30273-5 id = cord-320548-oigyut2k author = Zumla, Alimuddin title = Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options date = 2014-09-01 keywords = H1N1; MERS; infection; infl; treatment; uenza summary = doi = 10.1016/s1473-3099(14)70828-x